New Report Demonstrates High Costs and Low Benefits of Sarbanes-Oxley 404b Compliance for Emerging Biotechs
February 11, 2019
February 11, 2019
WASHINGTON, Feb. 11 -- The Biotechnology Innovation Organization issued the following news release:
* * *
- Resources for emerging growth biotech companies would be better used for science than compliance with Section 404(b), economists find.
* * *
Today, to recognize National Inventors' Day, the Biotechnology Innovation Organization (BIO) released a new report, "Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Em . . .
* * *
- Resources for emerging growth biotech companies would be better used for science than compliance with Section 404(b), economists find.
* * *
Today, to recognize National Inventors' Day, the Biotechnology Innovation Organization (BIO) released a new report, "Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Em . . .